AusPAR: Erenumab

Australian Public Assessment Report

AusPAR

AusPAR: Erenumab [Word, 891.73 KB]

AusPAR: Erenumab [PDF, 1.14 MB]

Attachment: Product Information: Erenumab [Word, 70.54 KB]

Attachment: Product Information: Erenumab [PDF, 404.73 KB]

Device/Product Name

Aimovig

Active ingredients

Erenumab

AusPAR Date

10 September 2019

Published

20 September 2019

Submission Number

PM-2017-02174-1-1

Submission Type

New biological entity

Decision

Approved